Fem Relief
North Safety Products LLC
North Safety Products LLC
DRUG FACTS
FULL PRESCRIBING INFORMATION
Active ingredient
In each tablet: Acetaminophen 500 mg, Pamabrom 25 mg
Purpose
Purpose: Pain reliever/Diuretic
Uses
For the relief of pain of the premenstrual and mentrual periods. Pain of dysmenorrhea. Temporary weight gain, bloating, swelling and/or full feeling associated with the premenstrual and menstrual periods.
Liver Warning: This product contains acetaminophen
Severe liver damage may occur if: you take: this with other products containing acetaminophen,Ask a doctor or pharmacist before using other drugs if you are not sure. 3 or more alcoholic drinks every day while using this product
Do Not Use: with any other product containing acetaminophen this will provide morethan the recommended dose (overdose) of acetaminophen and could cause serious health concerns
For more than 10 days unless directed by a doctor
For more than 3 days for fever unless directed by a doctor
When using this product do not exceed the recommended dose
Stop use and ask a doctor if: symptoms do not improve, pain or fever persists or gets worse, new symptoms ocur, redness or swelling is present
You feel faint, vomit blood, or have bloody or black stools, these are signs of stomach bleeding
If pregnant or breast feeding a baby, ask a health professional before using this product
keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
Inactive Ingredients: Corn Starch, DC yellow 10, FDC Blue 1, Microcrystalline Cellulose, Povidone, stearic acid
MM1
Adults and Children 12 years of age and over: Take 2 tablets with water every 6 hours while symptoms persist. Do not take any more than 8 tablets in 24 hours. Children under 12: consult a doctor
Fem ReliefAcetaminophen Pamabrom TABLET
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
